Role of immunoglobulin CDR-H3 in heterosubtypic immunity to influenza virus
Role of immunoglobulin CDR-H3 in heterosubtypic immunity to influenza virus
批准号:
7991091
负责人:
Harry William Schroeder
金额:
$18.31万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-05 至 2012-06-30
关键词:
AffectAgeAllelesAmericasAntibodiesAntibody RepertoireAntigen PresentationB-LymphocytesBinding SitesBone MarrowBone Marrow CellsCategoriesCellsChargeCompetenceCoupledDevelopmentDiseaseDominant-Negative MutationGene TargetingHumanImmuneImmune responseImmunityImmunoglobulinsImmunologistInbred BALB C MiceIndividualInfectionInfluenza A Virus, H1N1 SubtypeKnowledgeLaboratoriesLeadLifeMethodologyMononuclearMorbidity - disease rateMouse StrainsMusMutationPredispositionPrevalencePreventiveProductionReceptors, Antigen, B-CellResearch PersonnelResistanceRiskRoleSerumStagingT-LymphocyteTestingTransgenic MiceTransplantationTyrosineVaccinationVaccinesVirusVirus DiseasesWild Type MouseWorkagedanti-influenzaantigen bindingchemical propertyexperienceinfluenzavirusinterestmortalitymutantnovelpandemic diseasepressurepreventpublic health relevanceresponsetreatment strategyyoung adult
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): We seek to gain a better understanding of the role of the antibody repertoire as a whole in providing heterosubtypic immunity to influenza virus. We have found that we can group of antigen binding sites into categories defined by specific physical-chemical properties. We have shown that some categories are preferred at key stages of life, whereas others appear to be actively selected against, especially in young adults who typically are more resistant to heterosubtypic infection than aged individuals. Preliminary studies indicate that immunoglobulins using 'disfavored' categories of antigen binding sites can be found in aged individuals. Because the general principles of antibody repertoire control appear common to human and mouse, in order to study the role of repertoire control in heterosubtypic immunity we created mice whose repertoire is limited to one of these highly disfavored categories. We previously used these mice to show that when antibodies bearing antigen binding sites belonging to normally preferred categories were completely replaced by antibodies using a disfavored category, protection against heterosubtypic challenge with an H1N1 strain was severely compromised. However, these studies did not answer the question of whether it was the absence of the normally preferred repertoire or the presence of sequences belonging to a disfavored category that had impaired heterosubtypic immunity. In the present proposal, we test the hypothesis that the presence of disfavored immunoglobulin can have a dominant negative effect on protection against heterosubtypic infection. This is a key issue because, as noted above, the composition of the repertoire can change with age or disease. Mice heterozygous for altered IgH alleles containing mutations in the DH locus produce a normal repertoire from the normal allele, and disfavored antibodies from the gene targeted allele. These mice will be used to test whether the presence of these disfavored antibodies is sufficient to increase morbidity and mortality after mice are immunized with either an H3N2 or an H1N1 strain, and then challenged with homologous or heterologous viruses. The increase in morbidity and mortality will confirm that control of the global composition of the antibody repertoire is essential for properly protective immune responses to influenza virus. Two potential mechanisms that could underlie this increases susceptibility to infection will then be tested. Mice will be injected with sera or infused with bone marrow mononuclear cells from naove or immunized mice, and then challenged with homologous or heterologous viruses. An increase in morbidity after administration with the sera will point to a direct effect of soluble disfavored antibody. An increase in morbidity only after transfer of cells will suggest a direct role of immunoglobulin as a B cell receptor, perhaps by altering antigen presentation to T cells. We will then titer the effect to determine the threshold beyond which heterosubtypic immunity is impaired. Coupled with new means to evaluate repertoire diversity, this information will then be used to inform susceptibility to influenza virus infections and to guide vaccination and treatment strategies.
PUBLIC HEALTH RELEVANCE: We seek to understand how the composition of the totality of antibodies produced by the body may affect protection against influenza virus. We plan to use this information both to identify individuals at risk for greater morbidity and mortality, and to guide vaccination and treatment strategies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of the immunoglobulin DQ52 DH gene segment in fetal immunosuppression
-
批准号:10596627
-
项目类别:
-
资助金额:$18.56万
-
财政年份:2022
-
负责人:Harry William Schroeder
-
依托单位:
Role of the immunoglobulin DQ52 DH gene segment in fetal immunosuppression
-
批准号:10451016
-
项目类别:
-
资助金额:$22.28万
-
财政年份:2022
-
负责人:Harry William Schroeder
-
依托单位:
The pre-BCR CDR-H3 sensing site and H chain selection
-
批准号:9089913
-
项目类别:
-
资助金额:$18.38万
-
财政年份:2015
-
负责人:Harry William Schroeder
-
依托单位:
The pre-BCR CDR-H3 sensing site and H chain selection
-
批准号:8987028
-
项目类别:
-
资助金额:$22.05万
-
财政年份:2015
-
负责人:Harry William Schroeder
-
依托单位:
The Role of Immunoglobulin CDRH3 in Autoimmune Disease
-
批准号:8513453
-
项目类别:
-
资助金额:$36.63万
-
财政年份:2012
-
负责人:Harry William Schroeder
-
依托单位:
HLA Region and KIR Genomics in Common Variable Immune Deficiency
-
批准号:8320328
-
项目类别:
-
资助金额:$76.03万
-
财政年份:2010
-
负责人:Harry William Schroeder
-
依托单位:
HLA Region and KIR Genomics in Common Variable Immune Deficiency
-
批准号:8115993
-
项目类别:
-
资助金额:$57.06万
-
财政年份:2010
-
负责人:Harry William Schroeder
-
依托单位:
Role of immunoglobulin CDR-H3 in heterosubtypic immunity to influenza virus
-
批准号:8103875
-
项目类别:
-
资助金额:$21.76万
-
财政年份:2010
-
负责人:Harry William Schroeder
-
依托单位:
Role of IG CDR-H3 in Responses to HIV Vaccines
-
批准号:8489257
-
项目类别:
-
资助金额:$34.34万
-
财政年份:2010
-
负责人:Harry William Schroeder
-
依托单位:
HLA Region and KIR Genomics in Common Variable Immune Deficiency
-
批准号:8508841
-
项目类别:
-
资助金额:$48.66万
-
财政年份:2010
-
负责人:Harry William Schroeder
-
依托单位:
Role of IG CDR-H3 in Responses to HIV Vaccines
-
批准号:8294974
-
项目类别:
-
资助金额:$36.52万
-
财政年份:2010
-
负责人:Harry William Schroeder
-
依托单位:
HLA Region and KIR Genomics in Common Variable Immune Deficiency
-
批准号:7992670
-
项目类别:
-
资助金额:$57.01万
-
财政年份:2010
-
负责人:Harry William Schroeder
-
依托单位:
Role of IG CDR-H3 in Responses to HIV Vaccines
-
批准号:8103940
-
项目类别:
-
资助金额:$36.51万
-
财政年份:2010
-
负责人:Harry William Schroeder
-
依托单位:
Role of IG CDR-H3 in Responses to HIV Vaccines
-
批准号:7988553
-
项目类别:
-
资助金额:$38.04万
-
财政年份:2010
-
负责人:Harry William Schroeder
-
依托单位:
HLA*B Associated Genes and Memory B cells in patients with CVID
-
批准号:7869836
-
项目类别:
-
资助金额:$18.39万
-
财政年份:2009
-
负责人:Harry William Schroeder
-
依托单位:
HLA*B Associated Genes and Memory B cells in patients with CVID
-
批准号:7692277
-
项目类别:
-
资助金额:$21.08万
-
财政年份:2008
-
负责人:Harry William Schroeder
-
依托单位:
Immunoglobulin CDR-H3 and neutralizing antibodies to HIV
-
批准号:7623056
-
项目类别:
-
资助金额:$27.83万
-
财政年份:2008
-
负责人:Harry William Schroeder
-
依托单位:
HLA*B Associated Genes and Memory B cells in patients with CVID
-
批准号:7532996
-
项目类别:
-
资助金额:$17.68万
-
财政年份:2008
-
负责人:Harry William Schroeder
-
依托单位:
Immunoglobulin CDR-H3 and neutralizing antibodies to HIV
-
批准号:7458507
-
项目类别:
-
资助金额:$23.15万
-
财政年份:2008
-
负责人:Harry William Schroeder
-
依托单位:
BIOLOGICAL DEFINITION OF HOST DEFENSE DEFECTS IN MAN
-
批准号:7603161
-
项目类别:
-
资助金额:$4.07万
-
财政年份:2007
-
负责人:Harry William Schroeder
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: